Harmony Biosciences Holdings Income Statement (2019-2026) | HRMY

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	73.82M	80.73M	91.21M	85.31M	107.03M	117.21M	128.31M	119.13M	134.22M	160.27M	168.41M	154.62M	172.81M	186.04M	201.27M	184.73M	200.49M	239.46M	243.78M	215.39M
Cost of Revenue (Quarter)	17.02M	16.48M	6.51M	14.72M	20.16M	20.47M	26.89M	22.57M	25.01M	23.42M	26.89M	27.23M	32.14M	27.58M	8.51M	30.71M	38.15M	59.65M	-10.29M	44.51M
Gross Profit (Quarter)	61.13M	66.13M	73.40M	70.60M	88.11M	94.25M	101.42M	98.35M	109.21M	127.97M	125.26M	127.13M	140.67M	143.26M	146.86M	152.74M	162.34M	179.81M	175.23M	170.88M
Operating items
Research & Development (Quarter)	6.50M	11.74M	7.45M	7.58M	12.67M	40.55M	10.09M	13.29M	14.97M	17.50M	30.31M	22.19M	63.58M	25.39M	34.67M	34.54M	15.00M	54.96M	49.93M	69.38M
Selling, General & Administrative (Quarter)	14.30M	16.86M	18.20M	17.88M	22.16M	21.33M	22.64M	22.06M	22.81M	22.55M	27.87M	25.68M	27.22M	28.59M	28.86M	31.24M	33.92M	29.81M	57.56M	32.51M
Other Operating Expenses (Quarter)	17.02M	16.48M	19.11M	17.58M	20.16M	20.47M	21.07M	22.57M	24.53M	23.42M	26.89M	27.23M	28.51M	27.58M	27.60M	30.71M	65.23M	29.55M	29.18M	31.69M
Operating Expenses (Quarter)	37.82M	45.08M	44.77M	43.04M	54.99M	82.35M	53.81M	57.92M	62.31M	63.46M	85.06M	75.10M	119.31M	81.55M	91.13M	96.49M	114.16M	114.32M	136.67M	133.58M
Operating Income (Quarter)	23.31M	21.05M	28.63M	27.56M	33.12M	11.90M	47.61M	40.42M	46.90M	64.51M	40.20M	52.03M	21.36M	61.71M	55.73M	56.24M	48.18M	65.49M	-124.75M	8.33M
EBIT (Quarter)	23.31M	21.05M	28.63M	27.56M	33.12M	11.90M	47.61M	40.42M	46.90M	64.51M	40.20M	52.03M	21.36M	61.71M	55.73M	56.24M	48.18M	65.49M	-124.75M	8.33M
Non-operating items
Interest & Investment Income (Quarter)	-7.23M	-5.43M	20.01M	-4.17M	-3.93M	-3.99M	15.21M	3.09M	3.44M	4.11M	4.10M	4.43M	4.71M	4.93M	4.48M	5.04M	5.30M	5.73M	5.85M	5.76M
Other Non Operating Income (Quarter)	0.00M	-26.15M		-0.00M	0.04M	0.06M	0.07M	0.00M	-0.03M	-9.77M	-9.73M	-0.14M	0.04M	-0.12M	0.16M	-0.28M	-0.19M	-0.11M	-0.10M	-0.13M
Non Operating Income (Quarter)	0.00M		0.03M	-0.00M	0.04M	0.06M	0.07M	0.00M	-0.03M	-0.01M	0.19M	-0.14M	0.04M	-0.12M	0.16M	-0.28M	-0.19M	-0.11M	-0.10M	-0.13M
Net income details
EBT (Quarter)	16.09M	-10.52M	24.48M	23.39M	29.23M	7.97M	44.10M	37.78M	44.09M	51.83M	39.69M	51.78M	21.69M	62.17M	56.16M	57.18M	49.64M	67.49M	40.76M	39.69M
Tax Provisions (Quarter)	1.97M	-0.90M	5.42M	1.90M	5.70M	-79.98M	81.54M	8.29M	9.79M	13.37M	13.08M	13.45M	10.10M	16.08M	-22.79M	11.62M	9.86M	16.62M	3.65M	7.20M
Profit After Tax (Quarter)	14.12M	-9.62M	22.71M	21.48M	23.53M	87.94M	48.51M	29.48M	34.30M	38.46M	26.61M	38.33M	11.59M	46.09M	49.48M	45.56M	39.78M	50.87M	22.49M	32.49M
Income from Continuing Operations (Quarter)	14.12M	-9.62M	19.06M	21.48M	23.53M	87.94M	-37.43M	29.48M	34.30M	38.46M	26.61M	38.33M	11.59M	46.09M	78.94M	45.56M	39.78M	50.87M	37.11M	32.49M
Consolidated Net Income (Quarter)	14.12M	-9.62M	19.06M	21.48M	23.53M	87.94M	-37.43M	29.48M	34.30M	38.46M	26.61M	38.33M	11.59M	46.09M	78.94M	45.56M	39.78M	50.87M	37.11M	32.49M
Income towards Parent Company (Quarter)	14.12M	-9.62M	19.06M	21.48M	23.53M	87.94M	-37.43M	29.48M	34.30M	38.46M	26.61M	38.33M	11.59M	46.09M	78.94M	45.56M	39.78M	50.87M	37.11M	32.49M
Preferred Dividend Payments (Quarter)
Net Income towards Common Stockholders (Quarter)	14.12M	-9.62M	22.71M	21.48M	23.53M	87.94M	-37.43M	29.48M	34.30M	38.46M	26.61M	38.33M	11.59M	46.09M	78.94M	45.56M	39.78M	50.87M	37.11M	32.49M
Additional items
EPS (Basic) (Quarter)	0.25	-0.17	0.39	0.36	0.40	1.48	0.82	0.49	0.57	0.64	0.46	0.68	0.20	0.81	0.87	0.79	0.69	0.88	0.40	0.56
EPS (Weighted Average and Diluted) (Quarter)	0.24	-0.17	0.38	0.35	0.39	1.44	0.79	0.48	0.56	0.63	0.45	0.67	0.20	0.79	0.85	0.78	0.68	0.87	0.39	0.55
Shares Outstanding (Weighted Average) (Quarter)	56.94M	57.72M	57.53M	58.91M	59.06M	59.23M	59.17M	59.73M	59.85M	59.86M	59.47M	56.77M	56.80M	56.87M	56.89M	57.31M	57.47M	57.55M	57.49M	57.82M
Shares Outstanding (Diluted Average) (Quarter)	58.59M	58.78M	59.21M	60.59M	60.92M	60.92M	61.10M	61.22M	60.74M	60.68M	60.37M	57.60M	57.54M	57.75M	57.87M	58.52M	58.47M	58.72M	58.54M	58.78M
EBITDA (Quarter)	14.12M	-9.62M	22.71M	21.48M	23.50M	87.79M	48.54M	29.61M	33.81M	38.47M	27.12M	38.16M	11.53M	46.83M	49.04M	45.74M	39.77M	50.98M	22.48M	31.73M
Interest Expenses (Quarter)								5.73M	6.22M	7.01M	4.80M	4.54M	4.40M	4.35M	4.21M	3.84M	3.65M	3.62M	3.55M	3.23M
Tax Rate (Quarter)	12.26%	8.57%	22.13%	8.12%	19.50%	-1,003.84%	184.88%	21.96%	22.21%	25.80%	32.96%	25.97%	46.57%	25.86%	-40.58%	20.32%	19.87%	24.63%	8.95%	18.14%

Research Tools

Developers

Harmony Biosciences Holdings Income Statement (2019-2026) | HRMY

Research Tools

Developers

Harmony Biosciences Holdings Income Statement (2019-2026) | HRMY

Create an account

Sign In

Reset Password